[object Object]
CoinDeskhisse online bot · 18 Ağustos 2026 01:27
Özet
Kraken's parent Payward joins Anthropic’s Project Glasswing, taps Claude Mythos 5 for security Search / News Video Prices Research Events Data & Indices More Sponsored Search / en Sign In Sign Up Tech Kraken parent Payward joins Anthropic’s Project Glasswing for AI security push…
#HYPE
Kraken's parent Payward joins Anthropic’s Project Glasswing, taps Claude Mythos 5 for security Search / News Video Prices Research Events Data & Indices More Sponsored Search / en Sign In Sign Up Tech Kraken parent Payward joins Anthropic’s Project Glasswing for AI security push Payward will use Anthropic’s cybersecurity model to hunt vulnerabilities and share open-source findings.
By Will Canny | Edited by Aoyon Ashraf 15 min ago 2 min read Make preferred on Share Share this article Copy link X icon X (Twitter) LinkedIn Facebook Email Make preferred on Kraken parent Payward joins Anthropic’s Project Glasswing for AI security push.
(CoinDesk) Summary Show Kraken parent Payward has joined Anthropic’s Project Glasswing and gained access to Claude Mythos 5, its frontier AI model for finding and fixing software vulnerabilities.
Payward plans to deploy the model across its environments to identify security flaws before they can be exploited.
The company said vulnerabilities found in third-party open-source software will be disclosed to project maintainers, potentially benefiting the broader crypto ecosystem.
Kraken parent Payward has joined Anthropic’s Project Glasswing, giving the crypto company access to Claude Mythos 5, an artificial intelligence model designed to find and fix software vulnerabilities.
İlgili: #HYPE
Bu özet bilgilendirme amaçlıdır, yatırım tavsiyesi değildir.
— hisseonlinebot
Bu haberi beğendiniz mi?
Yorumlar (0)
İlk yorumu sen yaz.
İlgili haberler
- For young Americans, the workplace is the new phoneless frontier. 'It allows us to hyper focus on the task at hand,' says employer
- Moderna’s personalized mRNA shot could reshape the fight against skin cancer — but it may also be overhyped
- Call-buying bonanza around Trump's Hyperliquid comments includes some eyebrow-raising trades
- Hyperliquid Strategies shares jump on Trump regulatory remarks